| 1 | [SID26725077] | Active | Potency | 3.1623 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID26725077] | Active | Potency | 3.1623 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 3 | [SID26725077] | Active | Potency | 3.1623 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 4 | [SID26725077] | Active | IC50 | 3.5 | Dose Response confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay [AID540297, Type: confirmatory] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | IC50 | 3.5 [uM] | | BioAssay | Dose Response confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay | | AID | 540297 | | BioAssay type | confirmatory | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 5 | [SID26725077] | Active | Potency | 8.191 | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen [AID686980, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 8.191 [uM] | | BioAssay | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen | | AID | 686980 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID26725077] | Active | Potency | 8.9125 | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2517, Type: confirmatory] | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) | | AID | 2517 | | BioAssay type | confirmatory | | Target | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] | | PubMed | | | Data Table |  |
|
| 7 | [SID26725077] | Active | Potency | 10 | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 8 | [SID26725077] | Active | Potency | 12.5893 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 9 | [SID26725077] | Active | Potency | 12.5893 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 10 | [SID26725077] | Active | Potency | 12.5893 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 11 | [SID26725077] | Active | Potency | 12.5893 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 12 | [SID26725077] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 13 | [SID26725077] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 14 | [SID26725077] | Active | Potency | 15.8489 | qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase [AID602233, Type: confirmatory] | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase | | AID | 602233 | | BioAssay type | confirmatory | | Target | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] | | PubMed | | | Data Table |  |
|
| 15 | [SID26725077] | Active | Potency | 22.3872 | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 16 | [SID26725077] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 17 | [SID26725077] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 18 | [SID26725077] | Active | Potency | 39.8107 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 19 | [SID26725077] | Active | Potency | 44.6684 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 20 | [SID26725077] | Active | AC50 | 46.273 | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity [AID504725, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | AC50 | 46.273 [uM] | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity | | AID | 504725 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 21 | [SID26725077] | Active | Potency | 89.1251 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 22 | [SID26725077] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) [AID652126, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) | | AID | 652126 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 23 | [SID26725077] | Active | | | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay [AID651999, Type: screening] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay | | AID | 651999 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID26725077] | Active | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 25 | [SID26725077] | Active | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 26 | [SID26725077] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 27 | [SID26725077] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 28 | [SID26725077] | Active | | | TRFRET-based biochemical high throughput confirmation assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID602124, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | TRFRET-based biochemical high throughput confirmation assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 602124 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 29 | [SID26725077] | Active | | | TRFRET-based biochemical high throughput confirmation assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID602124, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | TRFRET-based biochemical high throughput confirmation assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 602124 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 30 | [SID26725077] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 31 | [SID26725077] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 32 | [SID26725077] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 33 | [SID26725077] | Active | IC50 | | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP) [AID2014, Type: confirmatory] | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP) | | AID | 2014 | | BioAssay type | confirmatory | | Target | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] | | PubMed | | | Data Table |  |
|
| 34 | [SID26725077] | Active | | | uHTS Colorimetric assay for identification of inhibitors of Scp-1 [AID493091, Type: screening] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | uHTS Colorimetric assay for identification of inhibitors of Scp-1 | | AID | 493091 | | BioAssay type | screening | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 35 | [SID26725077] | Active | | | Single concentration confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay [AID540281, Type: screening] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay | | AID | 540281 | | BioAssay type | screening | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 36 | [SID26725077] | Active | IC50 | | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) [AID2012, Type: confirmatory] | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) | | AID | 2012 | | BioAssay type | confirmatory | | Target | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] | | PubMed | | | Data Table |  |
|
| 37 | [SID26725077] | Active | | | Differential Scanning Fluorimetry (Thermal Shift) Binding Assay for validation of Inhibitors of Scp-1 phosphatase [AID540329, Type: other] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Active | | BioAssay | Differential Scanning Fluorimetry (Thermal Shift) Binding Assay for validation of Inhibitors of Scp-1 phosphatase | | AID | 540329 | | BioAssay type | other | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 38 | [SID26725077] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 39 | [SID26725077] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 40 | [SID26725077] | Inactive | Potency | 0.8275 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Inactive | | Potency | 0.8275 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID26725077] | Inactive | IC50 | 15.641 | TRFRET-based biochemical high throughput dose response assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID602181, Type: confirmatory] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Inactive | | IC50 | 15.641 [uM] | | BioAssay | TRFRET-based biochemical high throughput dose response assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 602181 | | BioAssay type | confirmatory | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 42 | [SID26725077] | Inactive | IC50 | 15.641 | TRFRET-based biochemical high throughput dose response assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID602181, Type: confirmatory] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Inactive | | IC50 | 15.641 [uM] | | BioAssay | TRFRET-based biochemical high throughput dose response assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 602181 | | BioAssay type | confirmatory | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 43 | [SID26725077] | Inactive | IC50 | 67.456 | Counterscreen for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl): Fluorescence-based biochemical high throughput dose response assay to identify GFP inhibitors and fluorescence quenchers [AID602182, Type: confirmatory] | green fluorescent protein [Aequorea victoria] [gi:634009] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Inactive | | IC50 | 67.456 [uM] | | BioAssay | Counterscreen for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl): Fluorescence-based biochemical high throughput dose response assay to identify GFP inhibitors and fluorescence quenchers | | AID | 602182 | | BioAssay type | confirmatory | | Target | green fluorescent protein [Aequorea victoria] [gi:634009] | | PubMed | | | Data Table |  |
|
| 44 | [SID26725077] | Inactive | | | Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound [AID1979, Type: screening] | heat shock protein 90 [Candida albicans] [gi:994798] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Inactive | | BioAssay | Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound | | AID | 1979 | | BioAssay type | screening | | Target | heat shock protein 90 [Candida albicans] [gi:994798] | | PubMed | | | Data Table |  |
|
| 45 | [SID26725077] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN. [AID2016, Type: screening] | MEP2 [Saccharomyces cerevisiae] [gi:1302091] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN. | | AID | 2016 | | BioAssay type | screening | | Target | MEP2 [Saccharomyces cerevisiae] [gi:1302091] | | PubMed | | | Data Table |  |
|
| 46 | [SID26725077] | Inactive | Potency | | qHTS Assay for Activators of ClpP [AID651965, Type: confirmatory] | ClpP [Bacillus subtilis] [gi:2668494] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of ClpP | | AID | 651965 | | BioAssay type | confirmatory | | Target | ClpP [Bacillus subtilis] [gi:2668494] | | PubMed | | | Data Table |  |
|
| 47 | [SID26725077] | Inactive | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). [AID2177, Type: screening] | lysophospholipase II [Homo sapiens] [gi:4581413] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Inactive | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). | | AID | 2177 | | BioAssay type | screening | | Target | lysophospholipase II [Homo sapiens] [gi:4581413] | | PubMed | | | Data Table |  |
|
| 48 | [SID26725077] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID651957, Type: screening] | NCOA2 gene product [Homo sapiens] [gi:5729858] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 651957 | | BioAssay type | screening | | Target | NCOA2 gene product [Homo sapiens] [gi:5729858] | | PubMed | | | Data Table |  |
|
| 49 | [SID26725077] | Inactive | Potency | | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 50 | [SID26725077] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN. [AID2029, Type: screening] | citrate synthase 2 [Saccharomyces cerevisiae] [gi:171229] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26725077 | | CID | 16745395 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN. | | AID | 2029 | | BioAssay type | screening | | Target | citrate synthase 2 [Saccharomyces cerevisiae] [gi:171229] | | PubMed | | | Data Table |  |
|